Dopamine Receptor d1 Antikörper
Kurzübersicht für Dopamine Receptor d1 Antikörper (ABIN636878)
Target
Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Affinity chromatography purified
-
Immunogen
- DRD1 antibody was raised in rabbit using a synthetic peptide conjugated to KLH as the immunogen.
-
-
-
-
Applikationshinweise
-
IHC-P: 1-5 µg/mL
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- Purified by Immunoaffinity Chromatography and supplied in PBS with 0.1 % NaN3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -70 °C for long term storage.
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Andere Bezeichnung
- DRD1
-
Hintergrund
- Dopamine receptors are a class of metabotropic G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS). The neurotransmitter dopamine is the primary endogenous ligand for dopamine receptors. Activation of D1-like family receptors is coupled to the G protein G alphas, which subsequently activates adenylyl cyclase, increasing the intracellular concentration of the second messenger cyclic adenosine monophosphate (cAMP).
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-